Patients, parents & advocates protecting access to oral vancomycin (OVT) for PSC-IBD. Facing barriers with ANI vancomycin? Your story matters.
Share your journey. Add your voice. Help us protect access to ANI Pharmaceuticals Vancomycin.
PSC-IBD Access Project is a patient and family-led advocacy initiative built on one simple truth: oral vancomycin therapy (OVT) using ANI Pharmaceuticals’ vancomycin has changed and in many cases saved the lives of PSC and IBD patients, including children.
We are parents, patients, caregivers, and advocates who have witnessed firsthand the life altering impact of this treatment. We are uniting as a community to ensure ANI continues manufacturing this critical medication, that pharmacies understand its irreplaceable value, and that physicians have access to accurate, up to date research including the retraction of studies that have been used to incorrectly dismiss OVT as a treatment option.
This is a strength in numbers movement. Every story shared here becomes data. Every data point becomes leverage. Together we will make the case to ANI, to pharmacies, to the medical community, and to policymakers that access to the right vancomycin is not optional for the patients who depend on it.
Share your journey. Add your voice. Help us protect access.